Speaker illustration

Doctor Michele Russo

Catholic University of the Sacred Heart, Rome (Italy)

Member of:

European Society of Cardiology

Michele Russo, MD, received his MD in July 2014 from the University “Gabriele D’Annunzio” of Chieti-Pescara (Italy). He completed his residency in Cardiology in 2019 at Catholic University of the Sacred Heart - Policlinico “Agostino Gemelli” - Department of Cardiovascular and Thoracic Sciences - directed by Prof. Filippo Crea in Rome (Italy). Dr. Russo has been a Research Fellow at the Mass General Cardiac OCT Research Laboratory (directed by Prof. Ik-Kyung Jang) - Massachusetts General Hospital - Harvard Medical School - Boston (United States of America) from October 2018 to August 2019. Since November 2018, he has been continuing his training as a PhD student in Cardiovascular Research at Catholic University of the Sacred Heart - Rome (Italy). Dr Russo's research focuses on the mechanisms of atherosclerosis progression and on the pathophysiology of acute coronary syndromes.

Perilipin-2 is associated with a higher risk of microvascular obstruction in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: No Reflow

Session: Acute Coronary Syndromes ePosters

Thumbnail

Characteristics of non-culprit plaques in acute coronary syndrome patients with previous plaque disruption at the culprit lesion

Event: ESC CONGRESS 2019

Topic: Pathophysiology and Mechanisms

Session: Advanced plaque imaging

Thumbnail

This platform is supported by

logo Novo Nordisk